-
r37980778c78--91a304efe49284a93ec0fec2915028d6
BMI-Related Prescription Costs (2014 Chinese yuan) a, b. -
r37980778c78--5792829d1d3889bd876b8a1679a83e40
Annual Direct Medical Costs for Diabetes-Related Complications (2014 Chinese Yuan). -
Cost-Effectiveness of Saxagliptin versus Acarbose as Second-Line Therapy in T...
ObjectiveThis study assessed the long-term cost-effectiveness of saxagliptin+metformin (SAXA+MET) versus acarbose+metformin (ACAR+MET) in Chinese patients with type 2 diabetes... -
r37980778c78--bc13b51147ea12a9220d788d8f81729d
Base Case Results for Saxagliptin plus Metformin Compared with Acarbose plus Metformin (2014 Chinese yuan).